Investment Focuses

Translational Stage

We seek to find and incubate original and outstanding innovations in areas such as cell therapy, gene therapy and cancer vaccines from research institutes that address unmet medical needs.

Early Stage

We seek to invest in companies founded by top researchers having cutting-edge research and technological platforms, incubating breakthrough assets that have the potential to be globally competitive.

Growth Stage

We seek to invest in companies that have novel drug delivery systems with well-defined clinical values, competitive product pipelines and clear product launch plans.